Alzheimer’s Set to Move From the Most Daunting Global Health Crisis to the 21st Century’s Fiscal Nightmare

OECD and the Global Coalition on Aging Convene at Harris Manchester College, Oxford University to Shape New Approaches for Solutions

Oxford, UK (26 June 2013) – The Organization for Economic Cooperation and Development (OECD), Harris Manchester College, Oxford University and Global Coalition on Aging (GCOA) concluded on Friday 21 June, an “Expert Consultation on Unlocking Global Collaboration to Accelerate Innovation for Alzheimer’s Disease and Dementia.” Aimed at providing input to the OECD action agenda for Alzheimer’s disease and dementia, the Consultation brought together the highest level of global experts across health, economics, public policy, business, biotechnology, and beyond.

Its timing is aligned with UK Prime Minister David Cameron’s recent recognition that dementia is fast becoming the biggest pressure on care systems around the world.  “That’s why we’re using our G8 to bring together health ministers, clinical researchers and healthcare companies,” he said.  “If the brightest minds are working together on this then we’ve got a greater chance of improving treatments and finding scientific breakthroughs.  I’ve said before that we need an all-out fight-back against dementia that cuts across society. Now we need to cut across borders and spearhead an international approach that could really make a difference.”

The objectives of the Consultation included:

  • Providing a space for country experts and  policy makers, and  scientific, medical and academic experts to share views on the main scientific, technological and policy challenges Alzheimer’s and dementia raise in the context of creating a pathway for aging populations to be sources of economic growth in the 21st century; and
  • Creating an opportunity for multidisciplinary exchange on a collective action plan that maps the way forward.

“The impact of Alzheimer’s and dementia on individuals, families, health systems and national economies as populations age will become truly crippling, and no one nation or research organization can solve this global epidemic alone.” said Michael Hodin, Executive Director of GCOA.  “It requires global understanding, sharing and collaboration, and this Consultation was a critical step in our ongoing fight against Alzheimer’s – a fight we must win if we are truly to unlock our aging populations as new sources of economic growth.”

Alzheimer’s afflicts one in eight over 65 and one-half of all those over 85, and the economic, social and personal costs will only increase with age-related demographic change.  In 2010, the global cost of Alzheimer’s and dementias equalled 1 percent of global gross domestic product (GDP), or $604 billion.  The prevalence and cost, combined with the stigma, which prevents recognition of symptoms and subsequent treatments, signal an urgent call to action.

“Traditional strategies around healthcare services and investments in research are not enough to address the growing worldwide onslaught of Alzheimer’s and dementias,” said Marc Wortmann, Executive Director of Alzheimer’s Disease International.

“The global scale of the pending healthcare-economic crisis mandates a bold forward looking action plan to harmonize a multi-nation attack on the problem,” noted  Zaven Khachaturian, recognized at the meeting as the ‘Chief Architect’ of Alzheimer & Brain Aging research in the United States, now the President of the Campaign to Prevent Alzheimer’s Disease by 2020. He indicated the urgent need for a “multinational strategic goal for reducing the prevalence of Alzheimer’s and other chronic brain disorders, by 50% within a decade” – thus urging the OECD to “identify the framework conditions to accelerate multi-national collaborative R & D.”

George Vradenburg, Chairman of USAgainstAlzheimer’s and convener of the Global CEO Initiative on Alzheimer’s called for new attention, resources, commitment and collaboration to defeat Alzheimer’s disease.  In his keynote speech, coined “The Oxford Accord,” he called for G8 leadership equivalent to the G8 Summit that created the HIV/AIDS Global Fund.

Consultation experts presented their views for proactive public policy and an OECD role in supporting actions to : promote broad-based partnerships; identify incentives, frameworks and infrastructures for enhanced international data sharing; leverage big data as strategies to advance our understanding of Alzheimer’s disease, improve care, promote global exchange of good practice and move toward cure and even prevention.

The Consultation was borne out of the September 2012 OECD workshop, “Anticipating the Special Needs of the 21st Century Silver Economy: From Smart Technologies to Services Innovation,” co-hosted by the Asia-Pacific Economic Cooperation, OECD and Waseda University, with the support of the Japanese government.  The workshop concluded that innovation was needed to meet the challenges and opportunities of global demographic change and mitigate the health, social and economic impacts of aging.

The Consultation was held on 20-21 June, 2013 at The Harris Manchester College (HMC), Oxford University in collaboration with the Global Coalition on Aging and Oxford’s HMC.

For more information see OECD’s website:  oe.cd/innovating-against-alzheimers

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.